INK4c is a member of the INK4 family of proteins that regulate the G 1 to S cell cycle transition by binding to and inhibiting the pRb kinase activity of cyclindependent kinases 4 and 6. The p16
Progression through the cell cycle is monitored at the G 1 -S phase checkpoint by active complexes between cyclin-dependent kinases (CDK) 1 4 and 6 and the D-type cyclins (D1, D2, D3). The INK4 family of proteins plays a key role in inhibiting the G 1 -S phase cell cycle transition by specifically inhibiting the kinase activity of CDK4-Cyclin D and CDK6-Cyclin D complexes. The INK4 (inhibitors of CDK4) family of proteins consists of four known members: p16 INK4a , p15 INK4b , p18 INK4c , and p19 INK4d , which share 40% sequence identity overall and structural homology (1) (2) (3) (4) (5) .
The INK4 family members have indistinguishable CDK/cyclin inhibitory activity when assayed in vitro (6) , but appear to have distinct functions in vivo. For example, the locus on 9p21 (MTS1) expressing p16
INK4a is a frequent target of genetic alterations in cancer, while the genes encoding the other INK4 proteins are much less commonly mutated in cancer. Specifically, gene deletions in MTS1 and promoter methylation often lead to transcriptional silencing, and point mutations are frequently associated with several different types of cancer (7) (8) (9) (10) . Nearly 55 different residues are targeted in missense mutations of p16 INK4a (7) . Homozygous deletions of p15 INK4b have also been identified in a more limited number of cancer cell lines (11) , and point mutations of p18 INK4c have been associated with some breast carcinomas (12) . Homozygous deletions of the p18
INK4c are also observed in oligodendrogliomas (13) ; however, these deletions are rare. Polymorphisms of the p19
INK4d gene are found in a small percentage of osteosarcomas (14) . Together, the data on tumor-derived mutations suggest tissue-specific, and/or non-redundant activities for the INK4 proteins (15) .
Significant insights into the mechanism of INK4-mediated inhibition of cyclin-CDK complexes and the deleterious effects of tumor-derived mutations on their kinase inhibitory properties come from structural analyses of the INK4 proteins. The INK4 proteins contain four or five ankyrin repeat motifs that contain a ␤-strand helix-turn-helix ␤-strand segment that associates with neighboring motifs through ␤-sheet and helical bundle interactions. The ankyrin repeats stack on top of each other to form an elongated overall structure in which the helical region is along one side of the protein and the ␤-sheet region is along the opposite side (16, 17) . A mapping of p16 INK4a tumor-derived mutations onto the INK4 protein structures reveal that most of these mutations localize to residues involved in ankyrin repeat conformation or interrepeat interactions (17) , suggesting that a large percentage of p16
INK4a mutations decrease the stability of the protein. Indeed, several of these mutations lead to the decreased stability of p16
INK4a and p18
INK4c proteins when studied in vitro (18 -21) . Together, these studies suggest that the decreased thermostability of p16
INK4a correlate with its loss of function and tumorigenic properties.
The structure of INK4 proteins in binary complex with CDK6 (22, 23) and in ternary complex with CDK6 and a D-type viral cyclin (24) reveal that the INK4 protein binds next to the ATP binding site of the CDK. The resulting distortion of the kinase catalytic cleft prevents ATP binding and thereby inhibits catalysis (25). While, each of the first 4 ankyrin-repeat units of the INK4 proteins participate in CDK4 interaction, most of the interactions are mediated by the 2nd and 3rd ankyrin repeat units. In addition, comparison of the INK4 structures in the presence or absence of CDK reveals that the INK4 protein does not undergo significant structural rearrangement for CDK binding with an overall RMS deviation of less than 1.3 Å.
Based on the structure-function studies described above for the INK4 proteins, we hypothesized that we may be able to use a structure-based approach to prepare mutant INK4 proteins with increased stability and increased CDK4/6 and cell cycle inhibitory activity. The preparation of INK4 proteins with increased CDK4 inhibitory properties would potentially be useful for targeting p16
INK4a -mediated cancers and would provide a proof-of-principle for the design of "biophysical drugs" (small molecule compounds that may reactivate tumor derived p16
INK4a mutants by modifying the biophysical properties of the protein such as stability). Indeed, the design of such compounds for the reactivation of tumor-derived mutants of the p53 tumor suppressor has already been described (26) .
As both the native and complexed structures of p18
INK4c
have been described (17, 24) , we used p18
INK4c as the INK4 model of choice to carry out the initial structure-function studies. Since the INK4 proteins are highly homologous, we expect that the results of our studies with p18
INK4c would be transferable to other INK4 proteins such as p16 INK4a . In this report we describe the preparation, and functional and structural characterization of single-site mutant p18
INK4c proteins that are designed for increased stability. Through this study, we have identified at least one mutant, the F71N p18
INK4c mutant that has significantly increased stability in vitro and enhanced CDK4/6 and cell cycle inhibitory activity in vivo. We discuss the implications of these findings for improving the thermodynamic stability of the INK4 proteins as a means to increase their cell cycle inhibitory activities, and for the development of compounds for the treatment of p16
INK4a -mediated cancers.
MATERIALS AND METHODS

Cloning and Protein Purification-Single amino acid substitutions in p18
INK4c were produced using the QuickChange mutagenesis kit (Stratagene) using the pRSETA-p18
INK4c vector (17) as a template, and sequence changes were confirmed by DNA sequencing. Recombinant native and mutant p18
INK4c proteins were prepared by growing and inducing pRSETA-p18
INK4c (native or mutant) transformed BL21 (DE3) cells at 37°C. Cells were lysed and purified in a low salt buffer (LSB) containing 50 mM Tris (pH 8.5), 50 mM NaCl, 5 mM ␤-mercaptoethanol, and 0.1 mg ml Ϫ1 phenylmethylsulfonyl fluoride. Except for the F71N p18
INK4c mutant, all other recombinant proteins (including the native protein) were isolated by renaturing the protein found in the inclusion bodies with 6 M urea denaturation and renaturation by stepwise dialysis to remove urea. The soluble fraction from renaturation was further purified by cation exchange with a Q-Sepharose fast flow column (Amersham Biosciences) and gel filtration using a Superdex-75 column (Amersham Biosciences) (17) . The F71N p18
INK4c mutant was the only protein that was found exclusively in the soluble protein fraction, and the supernatant was directly purified using cation exchange and gel filtration chromatography (17) . Protein aliquots were flash-frozen at Ϫ70°C and thawed as needed for biophysical studies or crystallization.
Circular Dichroism-monitored Thermal Denaturation-Circular dichroism data for the thermal denaturation studies was collected on an AVIV circular dichroism spectrophotometer (Model 62A-DS) equipped with a thermoelectric unit and using a 1-mm pathlength cell. Thermal protein denaturation was monitored at 222 nm and was shown to be irreversible. Data was collected every 2°C with an equilibrium time of 4 min and an averaging time of 10 s. Protein samples were analyzed at a concentration of 2 mg ml Ϫ1 (ϳ20 M) in 50 mM HEPES pH 7.5. Protein concentrations were determined using UV spectrophotometry. However, concentration of the W5R mutant, which had a low extinction coefficient, was determined using a Bradford assay using the native protein as a standard. The melting temperature, T m and error estimates were calculated by fitting the denaturation data (molar ellipticities) to a non-linear dose-response logistical transition {y ϭ a 0 ϩ a 1 /(1 ϩ x/a 2 ) a3 )} using the Levenberg-Marquardt algorithm within the SlideWrite software package, where the a 2 coefficient is T m .
Circular Dichroism-monitored Urea Denaturation-Circular dichroism data for the urea denaturation studies was collected on a Jasco J-720 spectopolarimeter at 25°C. The CD signal at 222 nm was recorded using a 100-l cell containing a 0.2-mm pathlength. Protein samples were at a concentration of 2 mg/ml in a buffer containing 20 mM HEPES, 100 mM NaCl, and urea concentrations from 0 -6 M in increments of 0.5 M. Samples were equilibrated for 4 h (equilibration was shown to be complete after 3 h, data not shown) prior to analysis by CD, and all samples were prepared and recorded in duplicate yielding an average CD value that was used for all subsequent analysis. The fraction of unfolded protein (f u ) as a function of urea concentration was calculated with the equation f u ϭ ( (27) .
Crystallization and Structure Determination of p18 INK4c MutantsCrystallization of the F71N, F82Q, and F92N p18
INK4c mutants were carried out by vapor diffusion at room temperature, using 2-l hanging drops containing 5 mg ml Ϫ1 protein, 20 mM Tris (pH 8.5), 0.5 mM dithiothreitol, 7% PEG 6000 (polyethylene glycol, average molecular mass 6000 M r ), and 1 M NaCl equilibrated over a reservoir containing 14% PEG 6000 and 2 M NaCl. These conditions are similar to those used to crystallize the native protein. Crystals were transferred to a harvest solution (HS) containing 20 mM Tris (pH 8.5), 15% PEG 6000 and 2 M NaCl, transferred stepwise to HS supplemented with 25% glycerol, and frozen in liquid nitrogen-cooled liquid propane prior to data collection.
Diffraction data was collected at 110 K using a Rigaku Raxis IV image plate detector with CuK␣ radiation from a Rigaku RU-300 generator, and the data was processed and scaled using DENZO and SCALEPACK (28) . The structural coordinates of native p18
INK4c were used as a starting model for the mutant proteins. The position and orientation of these coordinates was initially adjusted using rigid body refinement with the program CNS (29) . Model building was carried out using the program O (30) using omit maps and sigma A weighted 2 F o Ϫ F c and F o Ϫ F c difference Fourier maps created with the program CNS (29) . Iterative rounds of model building followed by positional refinement, simulated annealing (31), and torsion angle dynamic (32) refinement protocols were carried out at successively higher resolution shells. At the final resolution shell, solvent molecules were added, and the final model was checked for errors with simulated annealing omit maps, omitting 10 residues at a time (33) . The resulting protein structures have excellent refinement statistics and geometry (Table IV) .
In Vivo p18 INK4c Stability and CDK6 Association-DNA encoding wild-type and mutant p18
INK4c proteins were subcloned into the pCDNA3.1 vector creating a set of pCDNA-p18
INK4c vectors (T85F was not tested due to complications in the subcloning). The cell culture conditions of the U2OS cells were essentially as described (34) . A total of 1 ϫ 10 6 U2OS cells were transfected using Superfect reagent (Qiagen Inc., Valencia, CA) with 0.5 g of green fluorescent protein reporter and 1.5 g of pCDNA-p18
INK4c (native or mutant), pCDNA-p21, or vector alone. After 24 h post-transfection, the cells were lysed, and the proteins were separated on a 15% SDS-PAGE. The proteins were blotted onto nitrocellulose filter paper and probed with anti-p18
INK4c antiserum (Oncogene Research), followed by horseradish-conjugated anti-rabbit IgG antibody. The reacting p18
INK4c bands were detected using enhanced chemiluminescence reagent for direct comparison of the in vivo stability of wild-type and mutant p18
INK4c proteins. The relative amount of wild-type and mutant p18
INK4c protein that is associated with CDK4/6 in vivo was determined using CDK6 co-immu-noprecipitation experiments. The p18
INK4c
-transfected U2OS cells were lysed and endogenous CDK6 was immunoprecipitated with CDK6 antiserum (BD PharMingen). These immunoprecipitates were analyzed on 15% SDS-PAGE, and the gels were blotted and probed with antip18
INK4c antiserum, followed by horseradish-conjugated anti-rabbit IgG antibody. The cell lysis was carried out in the presence of two different salt concentrations (150 mM and 250 mM) prior to immunoprecipitation to optimize the discrimination between the differing binding affinities of the p18
INK4c mutants for CDK6. In Vivo Cell Cycle Inhibition Assay-For cell cycle analysis, p18
INK4c -transfected cells were prepared in 1% fetal bovine serum/ phosphate-buffered saline for fluorescence-activated cell sorting (FACS) analysis after 24 h. Preparation of cells for fluorescenceactivated cell sorting was performed essentially as described (35). Cell sorting was performed on a Coulter Epics Elite counter. DNA content analysis was performed using MacCycle software (Phoenix Flow Systems, San Diego, CA).
RESULTS AND DISCUSSION
Design of p18
INK4c Mutant Proteins-The high-resolution crystal structure of p18
INK4c , was used to identify candidate residues for mutation. The strategy for the mutagenesis was to increase the hydrophobicity of the protein interior or to increase the hydrophilicity of the protein exterior. Accordingly, buried hydrophilic residues were changed to hydrophobic residues or exposed hydrophobic residues were changed to hydrophilic residues. In mutating hydrophobic residues to hydrophilic residues, mutations were selected to facilitate interactions with residues in neighboring repeats. Moreover, buried hydrophilic residues were mutated to hydrophobic residues of similar size that were predicted to facilitate favorable interactions with other hydrophobic residues in its vicinity. With the aid of the program O (36), we modeled several mutations choosing the ones that best fit the criteria described above. The nine mutations that were made, along with their corresponding degree of conservation and structural properties, are listed in Table I and illustrated on a schematic of the overall p18
INK4c structure in Fig. 1 . 5 of the 9 mutations selected are conserved among the INK4 proteins (Phe-37, His-75, Phe-82, Thr-85, and His-108). Six of the mutations were designed to increase the thermodynamic stability of p18 INK4c , and a subset of these residues are also predicted to be at the INK4-CDK interface based on the INK4 co-crystal structures (Phe-37 (F37H), Phe-71 (F71N), and Phe-82 (F82Q)) (22) (23) (24) . Therefore, while one set of mutations are predicted to have effects only on the thermodynamic stability of p18 INK4c , another subset are predicted to have effects on both the thermodynamic stability of p18
INK4c and interaction with CDK. As negative controls, 3 of 9 mutations were also prepared that were predicted to decrease the thermodynamic stability of p18 INK4c , these include His-75 (H75F), His-108 (H108L), and Thr-85 (T85F).
Characterization of the p18
INK4c Mutant Protein during Purification and Crystallization-When expressed in bacteria, some mutants behave significantly differently than the native protein. These mutants include F71N, F82Q, and F92N . Bacterial growths prepared at 37°C revealed that these mutants are found in the soluble fraction of the bacterial lysate whereas the native protein is found exclusively in the insoluble fraction when the bacteria are grown at 37°C. Surprisingly, F71N is found exclusively in the soluble fraction, while about 25% of F82Q and F92N are found in the soluble fraction (Table II) . Each of the proteins were purified essentially as described for the native protein and eluted from gel filtration in monomeric form. Following protein purification, all three of these proteins crystallize at room temperature (at 20°C), while the native protein precipitates when crystal trials are carried out at the same temperature. Despite the different crystal growth temperature, crystals of the three mutant proteins are isomorphous with crystals of the native protein that are obtained from the same crystallization condition, but at 4°C (Table II and 
FIG. 1. Residues of p18
INK4c targeted for mutations. The ankyrin repeat elements are shown in alternating red and orange, and the residues targeted for mutations are shown in red. Table III ). The increased solubility properties of the F71N, F82Q, and F92N mutant proteins suggested that they might also be more thermostable than the native protein.
Design of p18 INK4c Proteins with Enhanced Activities
Native p18 INK4c and each of the other mutant proteins were found exclusively in the insoluble protein fraction from a bacterial preparation that was grown at 37°C. Upon renaturation and subsequent purification, most of these proteins eluted as monomers from gel filtration chromatography. However, the T85F and H108L mutants yielded mixtures of aggregates and monomeric protein, while the H75F mutant protein yielded aggregated protein exclusively. Taken together, these results suggested that the three mutants, H75F, T85F, and H108L might be thermodynamically less stable than the native protein.
Thermodynamic Stability of p18 INK4c Protein Mutants in Vitro-CD-monitored thermal denaturation was used to qualitatively characterize and compare the thermodynamic stabilities of p18
INK4c and its mutant proteins. Since the p18
INK4c
protein has substantial helical content, the CD signal at a wavelength of 222 nm, which is sensitive to helix formation, could be monitored as a function of solution temperature to develop a melting isotherm for each protein. The melting profiles for the native and mutant p18 INK4c proteins are compared in Fig. 2a , and the respective melting temperatures that are derived from these profiles are tabulated in Table III . These data reveal that of the 8 mutant p18
INK4c proteins that could be purified to homogeneity, 3 were clearly more stable to thermal denaturation than the native protein while 3 were clearly less thermostable; while two proteins, F37H and R55V, exhibited comparable thermostability as the native protein. The p18 INK4c mutants that were most stable to thermal denaturation included F71N, F92N, and F82Q; and the melting temperature of these mutants are ϳ4°C higher than the native protein (p value Ͻ 0.001). The less stable class of mutants contains three mutants, W5R, T85F, and H108L with melting temperatures from 4 to 17°C less than the native protein (p value Ͻ 0.001). The H75F mutant may belong in the less stable category of p18
INK4c mutants; however, it was too unstable to be purified for further characterization (Table II and Table III) .
To more quantitatively assess the thermodynamic stability of p18
INK4c and the mutants that showed increased thermal stability, these proteins were analyzed with CD spectroscopy using chemical denaturation with urea. The urea-induced unfolding profiles for the native and mutant p18
INK4c proteins are compared in Fig. 2b , and the respective urea concentrations required to unfold 50% of the respective protein are tabulated a The solubility of the protein refers to the presence of the protein in either the soluble or insoluble fractions of the bacterial lysate when the protein is overexpressed at 37°C.
b The ability to renature the protein refers to whether the protein can be isolated in the soluble fraction after denaturation by 6 M urea followed by stepwise dialysis to remove urea.
c Molecular size is judged by size exclusion chromatography of the renatured protein.
d Crystallization was only carried out with a few mutants; the crystals so obtained were isomorphous to the crystals of the native protein.
e Not determined. f Not tested. 
Design of p18
INK4c Proteins with Enhanced Activities 48830 in Table III . In addition, the urea unfolding data was used to calculate the free energy of unfolding [⌬G(H 2 O)] and m (Table  III) . Correlating with the thermal denaturation studies, the most thermostable p18
INK4c mutant, F71N, was also the most stable to chemical denaturation. Specifically, this mutant was about 0.71 kcal/mol more stable than the native protein. Interestingly, the other p18
INK4c mutants that showed increased stability toward thermal denaturation did not exhibit increased stability toward chemical denaturation (Table III) . A correlation of these results with the aggregation properties of the recombinant p18
INK4c mutants prepared and purified from bacteria (Table II) suggests that the increased thermal stability of the F82Q and F92N p18
INK4c mutants might be due to their lower propensities to aggregate relative to the native protein. This would be consistent with their higher T m (which would be affected by protein aggregation) without a corresponding increase in stability due to urea denaturation (which should be independent of protein aggregation).
Structural Characterization of the p18 INK4c Mutant Proteins, F71N, F82Q, and F92N-To determine the structural basis for the enhanced stability properties of the three p18
INK4c mutants; F71N, F82Q, and F92N, we determined their high resolution crystal structures.
F71N-The structure of the F71N p18 INK4c mutant was determined to a resolution of 2.25 Å (Table IV) . Position 71 in p18
INK4c is located in the ␤4 strand and at the beginning of ankyrin repeat 3. The structure shows that asparagine 71 directly hydrogen bonds with arginine 79 in the ␣5 helix in the middle of the ankyrin repeat and also makes a water-mediated hydrogen bond with Asp-100 in the ␤5 strand at the end of the ankyrin repeat (Fig. 3, a and b) . Taken together, the F71N p18
INK4c mutation allows new intra-ankyrin repeat interactions that stabilize the tight turns in the structure resulting in the increased stability of the mutant protein.
The structure of the p18 INK4c /CDK-cyclin complex reveals that although phenylalanine 71 does not interact with CDK, it is nonetheless at the binding interface. Therefore, it is possible that an asparagine substitution at this position would also introduce favorable p18
INK4c -CDK contacts. Modeling studies suggests that an asparagine at position 71 would be in position to interact with a backbone NH of CDK (glycine 36 of CDK6). Interestingly, other INK4 proteins have a threonine in the corresponding position, which also does not participate in CDK interaction in the p16
INK4a and p19
INK4d complexes with CDK (22, 23). Taken together, it is therefore likely that an asparagine substitution in other INK4 proteins would increase their thermodynamic stabilities and possibly also their CDK interaction and cell cycle inhibitory activities.
F82Q-The crystal structure of the F82Q mutant was determined to 2.0 Å resolution (Table IV) . In the native protein, phenyalanine 82 is located in the turn between the ␣5 and ␣6 helices of ankyrin repeat 3. The structure of the glutamine mutant reveals that the glutamine at position 82 hydrogen bonds to the backbone nitrogen of glycine 48 on the turn between the ␣3 and ␣4 helices of ankyrin repeat 2. The glutamine mutant also makes a water-mediated hydrogen bond to arginine 117 in helix ␣8 in ankyrin repeat 4 (Fig. 3, c and d) . INK4c mutant are shown in green with CPK coloring, while the structure of the native protein, which lacks these new interactions are shown in gray. The mutation results in a new hydrogen-bonding interaction with arginine 79, and a water (shown in yellow)-mediated hydrogen bond with aspartate 100. Glycines are shown as green or gray spheres. c, same as a except that the F82Q mutant is shown. d, detailed interactions made in the F82Q p18
INK4c mutant are shown in green with CPK coloring, while the structure of the native protein, which lacks these, new interactions are shown in gray. The mutation results in new hydrogen bonding interaction with the backbone NH of glycine 48 and a water (shown in yellow)-mediated hydrogen bond with arginine 117. Glycines are shown as green or gray spheres. e, same as a except that the F92N mutant is shown. f, detailed interactions made in the F92N p18
INK4c mutant are shown in green with CPK coloring, while the structure of the native protein, which lacks these, new interactions are shown in gray. The mutation results in a new water-mediated hydrogen bond with arginine 54. Glycines are shown as green or gray spheres. Molscript objects for the electron density was created using CONSCRIPT, and the figures were prepared with the programs MOLSCRIPT (37) and RASTER3D (38) .
